Vimentin Protein

Vimentin Protein

Pathway Diagram

```mermaid
flowchart TD
VIM["VIM<br/>(Vimentin)"]

%% Autophagy pathway
BECN1["BECN1<br/>(Beclin-1)"]
MAP1LC3B["MAP1LC3B<br/>(LC3B)"]
ATG14["ATG14<br/>(Autophagy Protein)"]
PIK3C3["PIK3C3<br/>(VPS34)"]
UVRAG["UVRAG<br/>(Autophagy Regulator)"]
LAMP1["LAMP1<br/>(Lysosomal Protein)"]
Autophagy["Autophagy<br/>Pathway"]

%% Protein degradation
UPS["Ubiquitin-Proteasome<br/>System"]
HDAC6["HDAC6<br/>(Histone Deacetylase)"]

%% Cellular stress
H2AX["H2AX<br/>(DNA Damage Marker)"]
MAP3K5["MAP3K5<br/>(ASK1 Kinase)"]

%% Disease outcomes
Inflammation["Neuroinflammation"]
Senescence["Cellular<br/>Senescence"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
PD["Parkinson's<br/>Disease"]
MS["Multiple<br/>Sclerosis"]

%% Connections
VIM -->|"regulates"| BECN1
VIM -->|"regulates"| ATG14
VIM -->|"regulates"| Autophagy
VIM -->|"associated with"| MAP1LC3B
VIM -->|"associated with"| PIK3C3
VIM -->|"associated with"| UVRAG
VIM -->|"associated with"| LAMP1
VIM -->|"regulates"| UPS
VIM -->|"associated with"| HDAC6
VIM -->|"regulates"| H2AX
VIM -->|"associated with"| MAP3K5

BECN1 -->|"initiates"| Autophagy
ATG14 -->|"promotes"| Autophagy
MAP1LC3B -->|"mediates"| Autophagy
PIK3C3 -->|"activates"| Autophagy
UVRAG -->|"regulates"| Autophagy
LAMP1 -->|"completes"| Autophagy

VIM -->|"biomarker for"| Inflammation
VIM -->|"biomarker for"| Senescence
VIM -->|"biomarker f

Vimentin Protein

Pathway Diagram

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#4477AA; color:white;">Vimentin</th></tr>
<tr><td><strong>Gene</strong></td><td>[VIM](/genes/vim)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P08670" target="_blank">P08670</a></td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~57 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, intermediate filaments</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Type III intermediate filament protein</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">157 edges</a></td>
</tr>
</table>
</div>

Overview

Vimentin Protein is a type III intermediate filament protein encoded by the [VIM](/genes/vim) gene. It is expressed in mesenchymal cells, fibroblasts, and [astrocytes](/cell-types/astrocytes) in the central nervous system. Vimentin serves as a key marker of astrocyte reactivity and plays important roles in neuroinflammation, a hallmark of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@schnitzer1989].

Structure

Vimentin is a type III intermediate filament protein consisting of three distinct structural domains[@eriksson2009]:

The rod domain contains highly conserved helical segments (1A, 1B, 2A, 2B) separated by linker regions. Vimentin can form both homopolymers and heteropolymers with other intermediate filament proteins such as [GFAP](/proteins/gfap-protein) and nestin[@eldin2002].

Normal Function

In the Healthy CNS

In the healthy adult brain, vimentin is expressed at low levels in:

• Radial glia during development
• A subset of astrocytes in specific brain regions
• Certain neuronal populations

• Cell structure and mechanical integrity
• Organelle positioning within cells
• Signal transduction pathways
• Cell migration and wound healing
• Cytoskeletal organization

Astrocyte Reactivity

When astrocytes become reactive (a process called astrocytosis or astrogliosis), they upregulate vimentin along with [GFAP](/proteins/gfap-protein). This reorganization of the intermediate filament network is a hallmark of the astrocyte response to neural injury.

Role in Neurodegeneration

Alzheimer's Disease

Vimentin is significantly upregulated in reactive astrocytes surrounding amyloid-beta plaques in AD[@pekny2005]. Key associations include:

• Plaque-associated astrocytes: Vimentin-positive astrocytes accumulate around both diffuse and neuritic plaques
• Disease progression marker: Glial vimentin expression correlates with disease severity
• Neuroinflammation amplifier: Vimentin-expressing astrocytes secrete pro-inflammatory cytokines
• Tau pathology: Vimentin is found in astrocytes in tauopathies, including AD[@hol2019]

Parkinson's Disease

In PD, vimentin-positive astrocytes accumulate in the substantia nigra pars compacta[@fullerr2010]:

• Dopaminergic region specificity: Vimentin upregulation is particularly pronounced in the substantia nigra
• Neuroinflammation: Reactive astrocytes contribute to chronic neuroinflammation
• Disease progression: The extent of astrocyte reactivity correlates with dopaminergic neuron loss

Other Neurodegenerative Conditions

Vimentin is implicated in several other conditions:

• Multiple Sclerosis: Expressed in reactive astrocytes and [microglia](/cell-types/microglia-neuroinflammation) in MS lesions, participating in glial scarring
• Amyotrophic Lateral Sclerosis (ALS): Astrocyte vimentin expression increases in motor neuron disease
• Frontotemporal Dementia: Tau pathology in astrocytes is associated with vimentin upregulation

Biomarker Potential

Vimentin has emerged as a potential biomarker for neurodegenerative disease[@yang2018]:

• CSF vimentin: Elevated cerebrospinal fluid vimentin levels correlate with disease progression
• Peripheral markers: Vimentin fragments detected in blood may indicate neural injury
• Imaging target: PET ligands targeting vimentin are under development

Therapeutic Implications

Targeting Astrocyte Reactivity

Modulating vimentin expression in astrocytes represents a therapeutic strategy:

• Anti-inflammatory approaches: Reducing astrocyte reactivity may decrease neurotoxic inflammation
• Intermediate filament modulation: Altering vimentin-GFAP balance could modify astrocyte function
• Phosphorylation targeting: Vimentin phosphorylation status affects its assembly and function[@buttler2022]

Research Tools

• Vimentin-knockout mice: Show reduced astrocyte reactivity in some injury models
• Vimentin inhibitors: Under investigation for neuroinflammatory conditions

Key Publications

See Also

• [Genes/VIM](/genes/vim)
• [Proteins/GFAP](/proteins/gfap-protein)
• [Cell Types/Astrocytes](/cell-types/astrocytes)
• [Mechanisms/Neuroinflammation](/mechanisms/neuroinflammation)
• [Mechanisms/Astrocyte-Reactivity](/mechanisms/astrocyte-reactivity-4r-tauopathies)

External Links

• [GeneCards: VIM](https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIM)
• [UniProt: P08670](https://www.uniprot.org/uniprot/P08670)
• [Human Protein Atlas](https://www.proteinatlas.org/gene/VIM)

Pathway Diagram

The following diagram shows the key molecular relationships involving Vimentin Protein discovered through SciDEX knowledge graph analysis: